Hainan Boao Lecheng International Medical Tourism Pilot Zone

established by State Council approval in 2013 and covering roughly 20 square kilometers near the Boao Forum for Asia, the zone lets foreign innovative cell therapies and medical devices treat patients before their nationwide China registration, drawing thousands of international patients and physicians.

Country: China

physical-pilot-zone cn

Coverage

	CN	EU	US
regulatory-legal	✓	✓	✓

Regulatorsfdaefsanmpa

Verifiable facts

Fact	Value	Source
Affiliation	Established by State Council approval on February 28, 2013, located in Qionghai, Hainan Province, China.	en.hainan.gov.cn · en.herun-group.com · hnrws.cn
Research focus	Clinical real-world data application, medical technology R&D, stem cell research, regenerative medicine, cancer treatment, anti-aging, and rare diseases.	en.hainan.gov.cn · en.herun-group.com · hnrws.cn
Facility	Boao Super Hospital, Boao International Hospital of Jimin Health (International Regenerative Medicine Research Center), Boao Yiling Life Care Center, Hainan Real-world Data Research Institute, NMPA Key Laboratory for Real-World Data Research and Evaluation, Hainan Xinshengquan International Cell Therapy Hospital, Ciming Boao International Hospital, Shulan (Boao) Hospital.	media.drugdu.com · boaolechengglobalinvestmentfund.com · realworlddatabase.com · en.hainan.gov.cn · hnrws.cn · thebionews.net
Grant	Hainan Xinshengquan International Cell Therapy Hospital investment of 465 million yuan ($66.6 million).	boaolechengglobalinvestmentfund.com
Publications	Clinical evaluations of 21 drugs and medical devices approved by NMPA based on real-world data as of June 2025; 470+ innovative medicines and devices introduced.	en.hainan.gov.cn · hnrws.cn
Principal staff	Luo Qingming (Honorary President, Hainan Real-world Data Research Institute), Qu Jia (Executive President), Chen Pingyan (Executive President), Yao Chen (Vice President), Sun Xin (Vice President), Fu Sheng (Director, Pilot Zone Administration).	hnrws.cn
Headcount	Workforce for some participating entities (e.g., Winhealth Pharma Group) involves 300-400 employees; total zone headcount not specified. medium confidence	en.hainan.gov.cn

Independent sources: boaolechengglobalinvestmentfund.com · en.hainan.gov.cn · en.herun-group.com · hnrws.cn · media.drugdu.com · realworlddatabase.com · thebionews.net

Technologies

Name	Cluster	Risk
Regulatory sandboxes for biotech	regulatory-legal	Medium	→

Compiled by BIOECON from primary sources.

Compliance Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.